Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mycobacterium tuberculosis hijacks host TRIM21- and NCOA4-dependent ferritinophagy to enhance intracellular growth
Youchao Dai, … , Xinchun Chen, Yi Cai
Youchao Dai, … , Xinchun Chen, Yi Cai
Published April 17, 2023
Citation Information: J Clin Invest. 2023;133(8):e159941. https://doi.org/10.1172/JCI159941.
View: Text | PDF
Research Article Immunology Infectious disease

Mycobacterium tuberculosis hijacks host TRIM21- and NCOA4-dependent ferritinophagy to enhance intracellular growth

  • Text
  • PDF
Abstract

Ferritin, a key regulator of iron homeostasis in macrophages, has been reported to confer host defenses against Mycobacterium tuberculosis (Mtb) infection. Nuclear receptor coactivator 4 (NCOA4) was recently identified as a cargo receptor in ferritin degradation. Here, we show that Mtb infection enhanced NCOA4-mediated ferritin degradation in macrophages, which in turn increased the bioavailability of iron to intracellular Mtb and therefore promoted bacterial growth. Of clinical relevance, the upregulation of FTH1 in macrophages was associated with tuberculosis (TB) disease progression in humans. Mechanistically, Mtb infection enhanced NCOA4-mediated ferritin degradation through p38/AKT1- and TRIM21-mediated proteasomal degradation of HERC2, an E3 ligase of NCOA4. Finally, we confirmed that NCOA4 deficiency in myeloid cells expedites the clearance of Mtb infection in a murine model. Together, our findings revealed a strategy by which Mtb hijacks host ferritin metabolism for its own intracellular survival. Therefore, this represents a potential target for host-directed therapy against tuberculosis.

Authors

Youchao Dai, Chuanzhi Zhu, Wei Xiao, Kaisong Huang, Xin Wang, Chenyan Shi, Dachuan Lin, Huihua Zhang, Xiaoqian Liu, Bin Peng, Yi Gao, Cui Hua Liu, Baoxue Ge, Stefan H.E. Kaufmann, Carl G. Feng, Xinchun Chen, Yi Cai

×

Figure 5

Mtb-induced proteasomal degradation of HERC2 depends on TRIM21.

Options: View larger image (or click on image) Download as PowerPoint
Mtb-induced proteasomal degradation of HERC2 depends on TRIM21.
(A) RT-q...
(A) RT-qPCR analysis of HERC2 in THP-1–derived macrophages infected with H37Rv for 2, 6, 12, and 24 hours. (B) Immunoblot analysis and quantitative analysis of HERC2 in THP-1–derived macrophages infected with H37Rv for various times (1, 2, 4, 8, 12, and 24 hours) in the presence of cycloheximide (CHX; 10 μM). (C) Immunoblot analysis of HERC2 and NCOA4 in THP-1–derived macrophages infected with H37Rv for 24 hours, followed by MG-132 (10 μM) for a further 3 hours. (D) Immunoblot analysis and immunoprecipitation of HERC2 and HA-Ub in THP-1–derived macrophages transfected with HA-Ub plasmid, followed by H37Rv infection for 24 hours. (E) Immunoblot analysis and immunoprecipitation of HERC2 and TRIM21 in THP-1–derived macrophages infected with H37Rv for 24 hours. (F) Immunoblot analysis of HERC2 and TRIM21 in THP-1–derived macrophages transfected with TRIM21 siRNA and then infected with H37Rv for 24 hours. (G and H) RT-qPCR analysis (G) and immunoblot analysis (H) of TRIM21 in THP-1–derived macrophages infected with H37Rv for 0, 6, 12, and 24 hours. (I and J) RT-qPCR analysis (I) and immunoblot analysis (J) of TRIM21 in THP-1–derived macrophages infected with H37Rv for 24 hours in the presence of p38 inhibitor (SB202190, 10 μM), JNK inhibitor (SP600125, 20 μM), NF-κB inhibitor (JSH-23, 30 μM), or AKT1 inhibitor (AKTi, 10 μM). Data in A–C, E, F, I, and J are representative of 2 or 3 independent experiments. Data are presented as means ± SD; **P < 0.01, ***P < 0.001, ****P < 0.0001 by Student’s 2-tailed unpaired t test (G and I).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts